Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
NCT05520788
·
clinicaltrials.gov ↗
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma
Biliary Tract Cancer
Interventions
GENETIC:
precise medicine
Sponsor
Tongji Hospital